XHKG8372
Market cap9mUSD
Dec 24, Last price
0.09HKD
1D
1.14%
1Q
5.95%
IPO
-73.03%
Name
Grand Brilliance Group Holdings Ltd
Chart & Performance
P/E
9.06
P/S
0.87
EPS
0.01
Div Yield, %
4.49%
Shrs. gr., 5y
—
Rev. gr., 5y
7.13%
Revenues
82m
+6.78%
Net income
8m
+3.87%
CFO
7m
-46.93%
Dividend
Jul 15, 20240.0025 HKD/sh
Profile
Grand Brilliance Group Holdings Limited, an investment holding company, engages in supplying of medical devices in Hong Kong. It offers medical consumables; medical instruments; and medical equipment, as well as develops healthcare products. The company also provides medical device solutions, such as market trend analysis, sourcing of medical devices, after-sale services, technical support and training services, medical devices leasing services, and quality assurance services; and maintenance services, as well as holds trademarks. It sells its products to various private and public hospitals, private clinics, non-profit organizations, universities, and individual end-users. The company was founded in 1997 and is based in Tsuen Wan, Hong Kong. Grand Brilliance Group Holdings Limited is a subsidiary of B&A Success Limited.
IPO date
Mar 29, 2018
Employees
41
Domiciled in
HK
Incorporated in
KY
Valuation
Title HKD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2024‑03 | 2023‑03 | 2022‑03 | 2021‑03 | 2020‑03 | 2019‑03 | 2018‑03 | 2017‑03 | 2016‑03 | |
| Income | |||||||||
Revenues | 81,903 6.78% | 76,701 6.56% | 71,978 2.47% | ||||||
Cost of revenue | 80,715 | 71,349 | 68,126 | ||||||
Unusual Expense (Income) | |||||||||
NOPBT | 1,188 | 5,352 | 3,852 | ||||||
NOPBT Margin | 1.45% | 6.98% | 5.35% | ||||||
Operating Taxes | 420 | 1,815 | 1,430 | ||||||
Tax Rate | 35.35% | 33.91% | 37.12% | ||||||
NOPAT | 768 | 3,537 | 2,422 | ||||||
Net income | 7,855 3.87% | 7,562 86.81% | 4,048 -48.49% | ||||||
Dividends | (3,200) | (2,400) | (3,600) | ||||||
Dividend yield | 4.23% | 6.00% | |||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
| Debt | |||||||||
Debt current | 1,429 | 3,766 | 2,400 | ||||||
Long-term debt | 1,429 | 5,142 | 6,562 | ||||||
Deferred revenue | |||||||||
Other long-term liabilities | |||||||||
Net debt | (61,522) | (57,522) | (50,443) | ||||||
| Cash flow | |||||||||
Cash from operating activities | 6,718 | 12,658 | (3,334) | ||||||
CAPEX | (1,804) | (63) | (784) | ||||||
Cash from investing activities | (395) | (510) | (3,960) | ||||||
Cash from financing activities | (7,420) | (6,399) | (7,582) | ||||||
FCF | (4,563) | 5,230 | (9,834) | ||||||
| Balance | |||||||||
Cash | 60,466 | 61,858 | 55,745 | ||||||
Long term investments | 3,914 | 4,572 | 3,660 | ||||||
Excess cash | 60,285 | 62,595 | 55,806 | ||||||
Stockholders' equity | 48,285 | 44,672 | 39,510 | ||||||
Invested Capital | 56,420 | 58,033 | 58,480 | ||||||
ROIC | 1.34% | 6.07% | 4.18% | ||||||
ROCE | 1.13% | 5.21% | 3.93% | ||||||
| EV | |||||||||
Common stock shares outstanding | 800,000 | 800,000 | 800,000 | ||||||
Price | 0.07 -5.33% | 0.08 -6.25% | |||||||
Market cap | 56,800 -5.33% | 60,000 -6.25% | |||||||
EV | (722) | 9,557 | |||||||
EBITDA | 5,804 | 9,718 | 8,104 | ||||||
EV/EBITDA | 1.18 | ||||||||
Interest | 106 | 152 | 140 | ||||||
Interest/NOPBT | 8.92% | 2.84% | 3.63% | ||||||